한글목차

패혈증은 감염으로 인한 생명을 위협하는 합병증으로, 감염에 대한 신체의 반응이 자신의 조직과 장기를 손상시킴으로써 발생합니다. 패혈증은 다발성 장기부전 및 사망을 유발할 수 있으며, 특히 조기에 발견하고 신속하게 치료하지 않으면 사망에 달할 수 있다(Elfeky et al., 2017)(Rudd et al., 2020). 패혈증은 누구에게나 발병할 수 있지만, 1세 미만의 어린이, 노인, 면역체계가 약한 사람에게서 더 흔하게 나타난다(Elfeky et al., 2017). 모든 감염(세균, 바이러스, 진균)이 패혈증을 유발할 수 있지만, 폐렴, 복부 감염, 신장 감염, 혈류 감염(균혈증)을 앓고 있는 사람은 패혈증에 걸리기 쉽습니다. 패혈증의 가장 흔한 병원체로는 세균(그람 양성, 그람 음성), 곰팡이 등이 있습니다(Quenot et al., 2013).

패혈증과 패혈증성 쇼크는 생명을 위협하는 질환으로 사망률이 매우 높습니다(Shankar-Hari et al., 2017)(Dupuis et al., 2020). 패혈증은 감염에 대한 숙주의 비정상적인 반응으로 인한 생명을 위협하는 장기 기능 장애로 정의됩니다(Singer et al., 2016)(Shankar-Hari et al., 2017). 패혈증성 쇼크는 지속적인 동맥성 저혈압을 특징으로 하는 급성 순환 부전 상태이며, 수액 소생술로 생명을 구할 수 없는 상태로 정의됩니다(Singer et al., 2016)(Shankar-Hari et al., 2017). 패혈증과 패혈증성 쇼크의 진단에는 임상 데이터, 검사 데이터, 생리적 데이터, 미생물학적 데이터의 조합이 필요합니다(Singer et al., 2016).

주요 8 시장(미국, 프랑스, 독일, 이탈리아, 스페인, 영국, 일본, 중국)의 패혈증에 대해 조사분석했으며, 패혈증 및 패혈증성 쇼크의 리스크 요인 및 과거 역학의 동향에 관한 정보를 제공하고 있습니다.

목차

제1장 목차

제2장 GlobalData 소개

제3장 패혈증 : 개요

• 촉매
• 관련 리포트
• 향후 리포트

제4장 역학

• 질환의 배경
• 위험 인자와 병존 질환
• 세계의 과거 동향
• 주요 8 시장의 예측 방법
• 패혈증과 패혈증성 쇼크의 역학적 예측(2023-2033년)
  • 패혈증으로 진단된 환자
  • 패혈증으로 진단된 환자 : 연령별
  • 패혈증으로 진단된 환자 : 성별
  • 패혈증으로 진단된 환자 : 병원체별
  • 패혈증으로 진단된 환자의 장기 기능 장애
  • 패혈증에 의한 원내 사망 예
  • 패혈증성 쇼크로 진단된 환자
  • 패혈증성 쇼크로 진단된 환자 : 연령별
  • 패혈증성 쇼크로 진단된 환자 : 성별
  • 패혈증성 쇼크로 진단된 환자 : 병원체별
  • 패혈증성 쇼크로 진단된 환자의 장기 기능 장애
  • 패혈증성 쇼크에 의한 원내 사망 예
• 인사이트
  • 역학적 예측 인사이트
  • COVID-19의 영향
  • 분석의 한계
  • 분석 강점

제5장 부록

제6장 문의

영문목차

Sepsis is a life-threatening complication arising from an infection, which occurs when the body's response to the infection damages its own tissues and organs. Sepsis causes multiple organ failure and death, especially if it is not recognized early and treated promptly (Elfeky et al., 2017; Rudd et al., 2020). Anyone can develop sepsis, but the condition is more common in children younger than one year of age, older adults, and those with weakened immune systems (Elfeky et al., 2017). Although any type of infection (bacterial, viral, or fungal) can lead to sepsis, people suffering from pneumonia, abdominal infection, kidney infection, and bloodstream infection (bacteremia) are more likely to develop sepsis. The most common pathogens for sepsis include bacteria (Gram-positive, Gram-negative), and fungi (Quenot et al., 2013).

Sepsis and septic shock are life-threatening conditions with an extremely high mortality rate (Shankar-Hari et al., 2017; Dupuis et al., 2020). Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection (Singer et al., 2016; Shankar-Hari et al., 2017). Septic shock is defined as a state of acute circulatory failure characterized by persistent arterial hypotension that cannot be successfully rescued by fluid resuscitation (Singer et al., 2016; Shankar-Hari et al., 2017). A constellation of clinical, laboratory, physiologic, and microbiologic data is needed for the diagnosis of sepsis and septic shock (Singer et al., 2016).

Scope

• This report provides an overview of the risk factors and the global and historical epidemiological trends for sepsis and septic shock in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China).
• Additionally, this report includes a 10-year epidemiological forecast of sepsis for men and women from 2023-33 for the following segmentations in all ages across the 8MM: diagnosed incident cases of sepsis segmented by sex and age (ages 0-28 days, 1 month-17 years, 18-64 years, and 65 years and older), diagnosed incident cases of sepsis by causative agent (Gram positive and Gram negative bacteria, fungi, and other organism), diagnosed incident cases of sepsis by organ dysfunction (acute kidney dysfunction, acute respiratory dysfunction, disseminated intravascular coagulopathy [DIC], hepatic dysfunction, and cardiovascular dysfunction), and in-hospital mortality of sepsis.
• This report also includes a 10-year epidemiological forecast of septic shock for men and women from 2023-33 for the following segmentations in all ages across the 8MM: diagnosed incident cases of septic shock segmented by sex and age (0-28 days, 1 month-17 years, 18-64 years, and 65 years and older), diagnosed incident cases of septic shock by causative agent, agent (gram positive and gram negative bacteria, fungi, and other organism) diagnosed incident cases of septic shock by organ dysfunction (acute kidney dysfunction, acute respiratory dysfunction, DIC, hepatic dysfunction, and cardiovascular dysfunction), and in-hospital mortality of septic shock.

Reasons to Buy

• Sepsis Epidemiology series will allow you to:
• Develop business strategies by understanding the trends shaping and driving the global sepsis markets.
• Quantify patient populations in the global sepsis markets to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis therapeutics in each of the markets covered.
• Understand magnitude of the sepsis population by age, sex, causative agent, and organ dysfunction.

Table of Contents

1. List of Contents

• 1.1. List of Tables
• 1.2. List of Figures

2. About GlobalData

3. Sepsis: Executive Summary

• 3.1. Catalyst
• 3.2. Related reports
• 3.3. Upcoming reports

4. Epidemiology

• 4.1. Disease background
• 4.2. Risk factors and comorbidities.
• 4.3. Global and historical trends
• 4.4. 8MM forecast methodology.
  • 4.4.1. Sources
  • 4.4.2. Forecast assumptions and methods.
  • 4.4.3. Forecast assumptions and methods: diagnosed incident cases of sepsis
  • 4.4.4. Forecast assumptions and methods: diagnosed incident cases of sepsis by causative agent.
  • 4.4.5. Forecast assumptions and methods: organ dysfunction in diagnosed incident cases of sepsis.
  • 4.4.6. Forecast assumptions and methods: sepsis in-hospital mortality cases.
  • 4.4.7. Forecast assumptions and methods: diagnosed incident cases of septic shock.
  • 4.4.8. Forecast assumptions and methods: diagnosed incident cases of septic shock by causative agent.
  • 4.4.9. Forecast assumption and methods: organ dysfunction in diagnosed incident cases of septic shock.
  • 4.4.10. Forecast assumption and methods: septic shock in-hospital mortality cases.
• 4.5. Epidemiological forecast for sepsis and septic shock (2023–33)
  • 4.5.1. Diagnosed incident cases of sepsis.
  • 4.5.2. Age-specific diagnosed incident cases of sepsis
  • 4.5.3. Sex-specific diagnosed incident cases of sepsis
  • 4.5.4. Diagnosed incident cases of sepsis by causative agent.
  • 4.5.5. Organ dysfunction in diagnosed incident cases of sepsis
  • 4.5.6. Sepsis in-hospital mortality cases
  • 4.5.7. Diagnosed incident cases of septic shock.
  • 4.5.8. Age-specific diagnosed incident cases of septic shock
  • 4.5.9. Sex-specific diagnosed incident cases of septic shock
  • 4.5.10. Diagnosed incident cases of septic shock by causative agent
  • 4.5.11. Organ dysfunction in diagnosed incident cases of septic shock
  • 4.5.12. Septic shock in-hospital mortality cases
• 4.6. Discussion
  • 4.6.1. Epidemiological forecast insight
  • 4.6.2. COVID-19 impact.
  • 4.6.3. Limitations of the analysis
  • 4.6.4. Strengths of the analysis

5. Appendix

• 5.1. Bibliography
• 5.2. About the Authors
  • 5.2.1. Epidemiologist
  • 5.2.2. Reviewers
  • 5.2.3. Vice President of Disease Intelligence and Epidemiology
  • 5.2.4. Global Head of Pharma Research, Analysis and Competitive Intelligence

6. Contact Us